Position in CVM
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$42,552
-$89,048 QoQ
Shares Held
40,916
-0.2% QoQ
Ownership
0.233%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#10
of 41 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CVM Over Time
Shares Held
Position Value (USD)
Derivatives in CVM
reported options exposure · as of Dec 31, 2021CallValue
$0
CallShares
0
PutValue
$874,009
PutShares
123,100
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,049,938,280 across 338 Biotechnology names. CVM ranks #323 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in CVM
Export CSV
32 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $42,552 | 40,916 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $131,600 | 40,997 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $215,622 | 40,993 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $376,997 | 40,978 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $93,846 | 40,981 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $411 | 1,791 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $660 | 1,655 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $15,537 | 14,658 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $34,337 | 29,602 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $55,685 | 29,155 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $83,151 | 30,571 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $17,999 | 14,400 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $77,410 | 32,121 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $74,520 | 32,121 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $75,586 | 32,165 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $109,572 | 35,461 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $448,008 | 99,558 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $694,009 | 176,593 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $874,009 | 123,100 | Put | Defined | 2022-02-08 | |
| 2021-12-31 | $1,730,260 | 243,699 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $1,383,640 | 125,900 | Put | Defined | 2021-11-15 | |
| 2021-09-30 | $684,389 | 62,274 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $5,503,987 | 634,100 | Put | Defined | 2021-09-13 | |
| 2021-06-30 | $219,141 | 25,247 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $1,402,846 | 92,232 | Shares | Defined | 2021-05-14 | |
| 2021-03-31 | $9,898,667 | 650,800 | Put | Defined | 2021-05-14 | |
| 2020-12-31 | $679,939 | 58,314 | Shares | Defined | 2021-02-10 | |
| 2020-12-31 | $4,926,349 | 422,500 | Put | Defined | 2021-02-10 | |
| 2020-09-30 | $1,305,801 | 102,416 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $2,454,339 | 164,500 | Put | Defined | 2020-08-14 | |
| 2020-06-30 | $3,655,547 | 245,010 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $136,967 | 11,869 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||